The primary decision-making body of the Consortium is the METRC Steering Committee.  It provides ongoing oversight in planning and conducting each study sponsored by the Consortium and votes on all important decisions.  It approves all study protocols and any amendments or modifications of the protocols.  It is comprised of the Principal Investigators (PIs) of each of the core clinical centers, representatives of the satellite centers (one per each of 4 geographic regions), the director, deputy director, principal biostatistician and principal economist of the Coordinating Center, the DOD Program Officer, the Orthopaedic Consultants for the Army, Navy, and Air Force, and representatives of our partner organization - the Armed Forces Institute for Regenerative Medicine (AFIRM). An Executive Committee serves as the agent of the Steering Committee in carrying out the day-to-day administrative responsibilities of the Consortium and Consortium-sponsored studies.


The Consortium is supported by a network of standing committees, and includes study-specific protocol committees. The study-specific protocol committees are responsible for developing the final protocol for the treatment trial, drafting the Standard Operating Procedures for the study, developing case report forms to supplement the information included in the core consortium database, making recommendations to the Steering Committee regarding changes to the protocol, monitoring progress of the trial, coordinating the analysis of the data and reporting of the results. All of these activities are facilitated by the Coordinating Center.


METRC Organizational Chart